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Abstract
Background:  The erythrocyte binding antigen-175 (EBA-175) on Plasmodium falciparum
merozoites mediates sialic acid dependent binding to glycophorin A on host erythrocytes and,
therefore, plays a crucial role in cell invasion. Dimorphic allele segments have been found in its
encoding gene with a 342 bp segment present in FCR-3 strains (F-segment) and a 423 bp segment
in CAMP strains (C-segment). Possible associations of the dimorphism with severe malaria have
been analysed in a case-control study in northern Ghana.
Methods: Blood samples of 289 children with severe malaria and 289 matched parasitaemic but
asymptomatic controls were screened for eba-175 F- and C-segments by nested polymerase chain
reaction.
Results: In children with severe malaria, prevalences of F-, C- and mixed F-/C-segments were 70%,
19%, and 11%, respectively. The C-segment was found more frequently in severe malaria cases
whereas mixed infections were more common in controls. Infection with strains harbouring the C-
segment significantly increased the risk of fatal outcome.
Conclusion: The results show that the C-segment is associated with fatal outcome in children
with severe malaria in northern Ghana, suggesting that it may contribute to the virulence of the
parasite.
Introduction
Malaria parasites invade host erythrocytes via interaction
between merozoite surface ligands and erythrocyte recep-
tors [1,2]. In Plasmodium falciparum, the erythrocyte bind-
ing antigen-175 (EBA-175) is one of the most important
ligands mediating erythrocyte invasion by sialic acid
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dependent binding to glycophorin A [3,4]. The 175 kDa
protein is located in micronemes at the apical end of the
merozoite [5]. Together with the Duffy-binding protein of
Plasmodium vivax (PvDBP), EBA-175 belongs to a family
of parasite adhesion molecules, the Duffy-binding-like
erythrocyte-binding proteins (DBL-EBP) [6]. This protein
family is characterized by a N-terminal signal peptide,
cystein-rich Duffy-binding-like (DBL) domains, a car-
boxyl cysteine-rich region (c-cys), a transmembrane
domain and a short cytoplasmatic tail. Encoding genes are
members of the erythrocyte-binding-like (ebl) gene fam-
ily. The eba-175 gene is located on chromosome 7 and
consists of four exons [7,8]. A large exon 1 is divided into
regions I-VI and codes for a tandem array of two DBL
domains in region II (Fl and F2) forming the putative lig-
and site as well as the c-cys domain, region VI. Both
domains have numerous conserved cystein and hydro-
phobic amino acid residues supporting their functional
relevance. They are separated by highly divergent dimor-
phic segments in region III [9]. This dimorphism is char-
acterized by an insertion of either a 342 bp segment in
FCR-3 strains (F-segment) or a 423 bp segment in CAMP
strains (C-segment) [7,10]. Both segments share little
homology and are located at slightly different positions
with the F-segment being 273 bp upstream of the C-seg-
ment. These two variants are conserved in all strains iso-
lated so far and since Plasmodium merozoites are haploid
either one or the other, but never both or neither segment
is present in one individual parasite clone [10]. The func-
tional relevance of the F-/C-segment dimorphism remains
unknown. Human IgG antibodies recognize epitopes on
the dimorphic F- and C-segments but are not associated
with protection from clinical malaria in The Gambia [11].
Population genetic analysis showed a C-segment allele
frequency of 73% in eba-175 of P. falciparum in a Sudanese
population whereas more than 70% of isolates from The
Gambia, Nigeria, Cameroon, Gabon, Tanzania and South
Africa carried the F-segment [12,13].
The two variants of the eba-175 dimorphism are evolu-
tionarily conserved suggesting functional relevance. F-
and C-segment frequencies vary in different ethnicities
and geographic regions. It is, therefore, hypothesized that
this dimorphism may influence clinical disease and
outcome.
Methods
Study area and parasites
Samples were collected between August and November
2002 in Tamale and its vicinity, Northern Region, Ghana.
Climate and vegetation are savannah-type. Malaria trans-
mission is perennial but highly seasonal and infection
rates are consistent with a hyperendemic malaria situta-
tion (Mockenhaupt et al., unpublished data). Blood sam-
ples and clinical data were obtained from 290 children
(aged 6 months to 9 years) with severe falciparum malaria
(SM) according to the current WHO definition [14]. One
sample was lost for genetic analysis. The clinical and par-
asitological characteristics of these children are described
in detail elsewhere [15]. For each patient with SM, one
age- and sex-matched asymptomatic but parasitaemic
control was randomly selected from a survey representa-
tive for Tamale and the surrounding six districts. For that
purpose, 30 communities and census units were recruited
following a two-stage cluster sampling strategy with prob-
ability proportional to population size. Within each unit,
≥70 children aged 6 months to 9 years were randomly
selected, clinical examinations were performed and
venous blood samples were taken. Parasites were counted
per ≥200 white blood cells on Giemsa-stained thick blood
films and P. falciparum was substantiated by specific PCR
assays [16].
DNA extraction and genotyping
Blood was stabilized (AS1, Qiagen, Hilden, Germany),
stored at 4°C and DNA was extracted by commercial kits
(QIAmp blood kit, Qiagen, Hilden, Germany). Genotyp-
ing of the eba dimorphism was performed by nested PCR
using primers EBA1 5'-CAAGAAGCAGTTCCTGAGGAA-3'
(forward) and EBA2 5'-TCTCAACATTCATAT-
TAACAATTC-3' (reverse) for the first amplification and
EBA3 5'-GAGGAAAACACTGAAATAGCACAC-3' (for-
ward) and EBA4 5'-CAATTCCTCC-AGACTGTTGAACAT-
3' (reverse) for the second amplification [17]. The follow-
ing mixture was used for 20 µl reaction volume [18]: 4 µl
(50–200 ng) of DNA-template for the first amplification
and 2 µl PCR-product for the nested PCR; 1 µl of each
primer (l00 µM), 1 U HotStarTaq Polymerase (Qiagen®,
USA); 1x PCR-Buffer, 1,5 mM magnesium chloride; and
200 µM dNTP. PCR was performed on T3 Thermocylcer
(Biometra®, Germany) using the following conditions:
Initial 5-min denaturation at 94°C followed by 29 cycles
with 1-min at 94°C, 1-min at 56°C and 2-min 72°C and
a 3-min final extension at 72°C. Amplicons were sepa-
rated on 1.5% ethidiumbromide stained agarose gels and
visualized using UV-translumination. A single band of
795 or 714 bp identified infection with parasites contain-
ing the F- or C-segment, respectively. Samples showing
both bands reflected mixed infection with a minimum of
two different clones.
Statistical analysis
Geometric mean parasite density (GMPD) and 95% con-
fidence intervals (95% CI) were calculated after log10
transformation. Genotype frequencies were compared
between case and control groups using Pearson Chi-
Square test and Fisher's exact test as applicable. Subgroup
analysis of the risk of individual symptoms was per-
formed by conditional logistic regression models. Associ-
ations between genotypes and fatal outcome in severeMalaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/11
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malaria cases were corrected for known predictors of mor-
tality (impaired consciousness, circulatory collapse,
hypoglycaemia and malnutrition [15]) by multiple logis-
tic regression analysis. A P-value < .05 was considered as
statistically significant.
Results
The median age of the 289 children with severe malaria
(154 girls, 135 boys) was 24 months (range 6–102). Mean
rectal temperature (±SD) was 38.6°C (±1.1). GMPD was
30,200/µL (95% CI, 22,474–40,581) and hyperparasitae-
mia (>250,000/µL) was present in 64 children (22%). The
GMPD of parasitaemic controls was 1,738/µL (95% CI,
1,387–2,178). Cases exhibited the following symptoms
defining severe malaria (WHO 2000): severe anemia
(55%), prostration (34%), respiratory distress (23%),
multiple convulsions (20%), impaired consciousness
(19%), jaundice (12%), circulatory collapse (3%), and
haemoglobinuria (3%). Case fatality rate was 11% (32/
284). For five children, no data on outcome were availa-
ble since they absconded during hospitalization.
In children with severe malaria, the F- and C-segment
were present in 70% (201/289) and 19% (55/289),
respectively (see Table 1). Both segments were found in
11% (33/289) representing mixed infections. In the para-
sitaemic controls, the prevalences for the F- and C-seg-
ment were 61% (176/289) and 17% (49/289),
respectively. Mixed infections were significantly less fre-
quent in severe cases than in parasitaemic controls (11%
(33/289) versus 22% (64/289); OR .5, [95% CI .3–.7], P
= .003; F-segment used as reference). Matched pair analy-
Table 1: Matched pair analysis of children with severe malaria and asymptomatic parasitaemic controls: risk of symptoms and 
conditions of severe malaria
Condition/Symptom Dimorphism Severe malaria Parasitaemic 
controls
OR [95% CI] P value (F-segment as reference)
absolute number (%)
All (n = 289) F-segment 201 (70) 176 (61)
F-/C-segment 33 (11) 64 (22) .5 [.3–.7] .003
C-segment 55 (19) 49 (17) 1.0 [.6–1.7] 1
Severe anaemia (n = 159) F-segment 114 (72) 95 (60)
F-/C-segment 18 (11) 37 (23) .4 [.2–.8] .02
C-segment 27 (17) 26 (16) .9 [.4–1.8] .9
Prostration (n = 97) F-segment 67 (69) 55 (57)
F-/C-segment 10 (10) 23 (24) .4 [.1–1.0] .06
C-segment 20 (21) 18 (19) .8 [.3–2.0]. .8
Respiratory Distress (n = 66) F-segment 40 (61) 47 (71)
F-/C-segment 9 (14) 10 (15) 1.2 [.4–3.7] 1
C-segment 17 (26) 9 (14) 2.0 [.8–7.7] .2
Multiple Convulsions (n = 59) F-segment 40 (68) 36 (61)
F-/C-segment 6 (10) 15 (25) .4 [.1–1.1] .1
C-segment 13 (22) 8 (14) 2.0 [.6–6.3] .4
Impaired Consciousness (n = 56) F-segment 36 (64) 39 (70)
F-/C-segment 8 (14) 9 (16) 1 [.3–3.6] 1
C-segment 12 (21) 8 (14) 1.6 [.5–4.6] .6
Jaundice (n = 34) F-segment 23 (68) 21 (62)
F-/C-segment 3 (9) 6 (18) .5 [.04–2.5] .7
C-segment 8 (24) 7 (21) 1 [.3–3.6] 1
Circulatory collapse (n = 10) F-segment 6 (60) 8 (80)
F-/C-segment 0 (0) 1 (10) -
C-segment 4 (40) 1 (10) 3.0 [.4–3.0] .6
Haemoglobinuria (n = 8) F-segment 6 (75) 5 (63)
F-/C-segment 0 (0) 1 (13) -
C-segment 2 (25) 2 (25) .5 [0–4.9] 1
Hyperparasitaemia (n = 64) F-segment 43 (67) 47 (73)
F-/C-segment 6 (9) 10 (16) .4 [.1–1.6] .3
C-segment 15 (23) 7 (11) 3. 7 [1.1–13.1] .06
Fatal outcome (n = 32) F-segment 15 (47) 18 (56)
F-/C-segment 4 (13) 7 (22) .5 [.04–2.5] .7
C-segment 13 (41) 6 (19) 4.0 [.9–19.4] .1Malaria Journal 2004, 3 http://www.malariajournal.com/content/3/1/11
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sis revealed no significant associations of the C- or F-seg-
ment with individual symptoms and conditions of SM
(Table 1). However, for all symptoms and conditions of
SM except for haemoglobinuria, the C-segment was more
common in severe cases while mixed infections occured
more often in respective parasitaemic controls (not
significant).
A trend towards a higher risk of dying of severe malaria
was found in children with the C-segment in matched pair
eba-175 dimorphism (F-segment, F-/C-mixed infection, C-segment): Percentage (absolute numbers) of severe malaria cases  with respective symptoms, conditions, and outcome Figure 1
eba-175 dimorphism (F-segment, F-/C-mixed infection, C-segment): Percentage (absolute numbers) of severe malaria cases 
with respective symptoms, conditions, and outcome.
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analysis (OR 4.0, [95% CI .9–19.4], P = .1; Table 1). Asso-
ciations of the eba-175 dimorphism with symptoms, con-
ditions, and outcome within the group of severe malaria
cases were re-tested (Figure 1). The C-segment was signif-
icantly associated with fatal outcome (case fatality rates: F-
segment: 8%, F-/C-segment: 13%, C-segment: 24%; _2
trend
= 11.3, P = .0008). Logistic regression analysis adjusting
for known predictors of death in these children [15] con-
firmed a six-fold increased risk of fatal outcome in
patients infected with C-segment parasites as compared to
F-segment parasites (OR 5.6, [95% CI 1.8–17.1], P < .003;
other predictors were: impaired consciousness, OR, 9.3;
95% CI, 3.4–25.9; P < .0001; circulatory collapse, OR,
35.9; 95% CI, 4.5–290; P = .0008; hypoglycemia, OR, 3.7;
95% CI, 1.3–10.3; P = .01; malnutrition, OR, 95% CI, 2.5;
1.0–6.3; P = .06).
Discussion
This study aimed at evaluating the frequencies of a dimor-
phic allele segment in the gene encoding the erythrocyte
binding antigen-175 on P. falciparum merozoites in chil-
dren with severe malaria in northern Ghana. Second,
associations of the eba-175 dimorphism with symptoms,
conditions, and outcome of severe disease were assessed
in a case-control analysis.
In 289 Ghanaian children with severe malaria, the F-seg-
ment predominated (70%). C-segment and mixed infec-
tions were present in 19% and 11%, respectively. These
findings are consistent with recently published data from
West Africa [13].
In the case-control analysis, mixed infections were signif-
icantly more common in controls than in cases. This is in
accordance with findings from other areas with high
transmission [19,20] and is considered to indicate
acquired immunity [21]. However, the presence of either
the F- or the C-segment alone does not exclude the possi-
bility of infection with different strains and, therefore,
limits validity of this finding. The overall distribution of
the F- and C-alleles did not differ significantly between
groups arguing against a role for the eba dimorphism in
mediating severe malaria per se. This is consistent with the
finding in the Gambia that antibodies against the dimor-
phism do not protect against clinical malaria [11]. Yet,
within the group of children with severe malaria, fatal out-
come was significantly associated with the C-segment
(Figure 1). These findings suggest that the C-segment of
the  eba-175  dimorphism on P. falciparum merozoites is
associated with fatality in severe malaria rather than pro-
moting disease progression from asymptomatic parasitae-
mia towards severe disease. A longitudinal study is needed
to confirm this.
Unlike in West Africa, in a Sudanese population the C-seg-
ment was most frequent [13]. This part of Africa repre-
sents an ethnically distinct region with lower malaria
endemicity. In a study conducted in Laos, the dimor-
phism was unequally distributed in distinct ethnic minor-
ities [18]. Random shifts in parasite allele frequencies in
different geographic regions can serve as an explanation.
Also, susceptibility to infection and disease severity vary
in different regions as does genetic variability in host pop-
ulations. On the other hand, not only genetic differences
in the host but also in the parasite may influence disease
severity and outcome. Although the functional mecha-
nism of the eba-175 dimorphism regarding disease sever-
ity remains unclear one might postulate that this
dimorphism offers alternative ways of erythrocyte inva-
sion to the parasite and therefore allows more rapid repli-
cation. Since the eba-175 dimorphism appears not to be
involved in the binding to neuraminidase- or trypsin-sen-
sitive erythrocyte receptors [22] it may recognize other, as
yet unknown, receptors. This explanation is supported by
the finding that the C-segment was associated at border-
line statistical significance with hyperparasitaemia (OR
3.7 [1.1–13.1] P = .06. see Table 1).
In conclusion, the C-segment of the eba-175 allelic dimor-
phism on P. falciparum merozites is not associated with
severe malaria per se but confers a higher risk of fatal dis-
ease in northern Ghana. These findings may contribute to
the development of a diagnostic tool predicting disease
outcome in children. Further studies are necessary to
reveal its functional relevance.
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